PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1299773
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1299773
Human Primary Cells market size was valued at USD 1,360.7 Million in 2022, expanding at a CAGR of 11.5% from 2023 to 2030.
Human Primary Cells are also known as mature cells extracted from living tissues of humans and animals after that processed to establish them for utilization in appropriate cell therapies. Additionally, Human Primary Cells are also used in several applications such as cancer research, 3D cell culture, tissue replacement, stem cell therapy, and virology. 3D cell culture is increasingly used by researchers to study cell biology and biochemistry, cell-pathogen interactions, drug effects, and cell signaling.
The primary cell market growth is attributed to the increasing geriatric population, advancements in development and research, and a rise in cases of chronic diseases. Additionally pharmaceutical market is growing significantly in advanced testing and drug development. This in turn projected to facilitate increased adoption of the Human Primary Cells market. However, restrictions implemented for the utilization of raw materials and expensive processes are the major factors hindering the market growth during the forecast period.
Moreover, primary cell cultures are used to identify the cytotoxicity of new drugs. Furthermore, Human Primary Cells are used in the place of animal models to test the effects of chemicals, cosmetics, and new drugs. These are some major factors expected to drive market growth. The COVID-19 pandemic has impacted the Human Primary Cells market positively. Human Primary Cells are used by researchers for understanding the infection. Characterized and standardized epithelium cell culture models are helping to understand the physical barrier devastated by the coronavirus. The models can assist mimic the properties and functions of the respiratory tract which leads to a breakthrough for a research outcome moving into a medical application
The global Human Primary Cells market is segmented on the basis of product type, separation, cell type, application, and region.
The market is divided into three categories based on product type: Human Primary Cells, reagents and supplements, and media. The reagents and supplements sector is expected to possess the market. Human Primary Cells are involved in reagents and supplements' routine application in manufacturing and research. The reagents and supplements are considered very crucial as Human Primary Cells are fragile for their growth.
The market is divided into three categories based on separation: explant method, enzymatic degradation, mechanical separation, and others. The enzymatic degradation sector is likely to maintain its dominance during the forecast period. This is partly due to its high preference at the place of other techniques for the separation of Human Primary Cells owing to its advantages such as comparatively fast, high yield of a representative sample, and less damage to cultures.
The market is divided into two categories based on cell type: animal and human. The animal sector is expected to hold the largest market share. For vaccine development, increasing the application of animal-origin Human Primary Cells are essential factor propelling the segment growth.
The market is divided into nine categories based on application: tissue culture & tissue engineering, vaccine production, gene therapy and regenerative medicine, toxicity testing & drug screening, virology, cancer research, stem cell therapy, model system, prenatal diagnosis, and others. The vaccine production sector is expected to dominate the market over the forecast period. Rising use of primary animal culture for the production of virus that is later utilized for producing various vaccines including hepatitis B and measles.
The Human Primary Cells market is rapidly driven globally by robust investment in research and development activities for the increment of better therapies where Human Primary Cells can be utilized to treat various immunodeficiency disorders. Additionally, with The growth in biopharmaceutical and biotechnology sectors, medical researchers are continuously working on using Human Primary Cells from human and animal tissues for the treatment of malignant cancers. Moreover, key players are adopting strategies such as new product launches, mergers & acquisitions, R&D spending, partnerships, and collaboration to enhance their market revenue. For instance, in August 2021, Axol Bioscience Ltd announced its merger with CENSO Biotechnologies. The merged entity will become a leading provider of service solutions and products. Additionally, it will provide customers with validated ready-to-use cell lines and a suite of services with robust functional data, customization capabilities, and broader expertise, all with shorter lead times.
This proposed research study on Human Primary Cells market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Human Primary Cells market.
The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Human Primary Cells market.
Impact of COVID-19 on Human Primary Cells market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Human Primary Cells market post-COVID will also be covered.
In order to give the users of this report a comprehensive view on the Human Primary Cells market, we have also included competitive landscape and key innovator analysis for Human Primary Cells market.
The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
The report offersdetailed company profiling featuring major market participantswhich will help users to understand their financial information and strategic initiatives of players operating in the Human Primary Cells market.
In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
The global Human Primary Cells market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.
The scope of this report covers the market by its major segments, which include as follows: